Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials

Volume: 45, Issue: 11, Pages: 1799 - 1806
Published: Apr 8, 2020
Abstract
Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety. We conducted the first systematic review and meta-analysis of the adverse effects of CBD across all medical indications. Double-blind randomized placebo-controlled clinical trials lasting ≥7 days were included. Twelve trials contributed data from 803 participants to the meta-analysis. Compared with placebo, CBD was...
Paper Details
Title
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Published Date
Apr 8, 2020
Volume
45
Issue
11
Pages
1799 - 1806
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.